Global Biotech & Pharma Patent (China) Summit 2026

会议时间：2026-06-04 08:30至 2026-06-05 17:00结束

会议地点：上海待定

会议规模：300人

主办单位：上海瞻仕商务咨询有限公司

发票类型：增值税普通发票

领取方式：会前快递

发票内容：会议费会务费

参会凭证：邮件/短信发送参会通知

门票名称	单价	截止时间	数量
早鸟票参会，午餐，茶歇，活动资料	￥3800.0	2026-06-01 17:00
合计：

会议通知
会议内容主办方介绍

The Global Biotech & Pharma Patent (China) Summit 2026 will bring together leading pharmaceutical companies, biotech firms, research institutions, law firms, intellectual property agencies, and industry experts from around the world. Centered on the core theme of "Focus on APAC Global Vision，Guided by Insight, Innovation Without Borders," and the summit will delve into patent strategies for cutting-edge technologies, global patent deployment and management, cross-border licensing and collaboration, as well as the latest trends in policies and ethics.

We are in an era of global health revolution driven by biotechnological innovation. From gene editing to AI-driven drug discovery, disruptive technologies are redefining pharmaceutical R&D. In this process, intellectual property—particularly patents—serves not only as a legal shield but also as a core strategic asset determining the value of technology transfer and global collaboration.China has emerged as an indispensable presence in this landscape. With substantial R&D investment and a maturing ecosystem, it has transitioned from a "fast follower" to a "parallel leader," contributing original achievements across multiple fields while deepening global collaboration.

However, the global patent landscape is increasingly complex, with regional differences in examination, cross-border enforcement challenges, and new models like open-source licensing. These demand more sophisticated IP strategies. Key questions now are: How to build a patent system combining international vision with local expertise? How to accelerate innovation through strategic IP management? The answers will determine the biopharmaceutical industry's success in the coming decade. These points are precisely part of the original intent behind hosting this summit and part of the key topics to be discussed with relevant professionals.

Join us on Jun 4th-5th! Register now to reserve your place at this exclusive event.

Day 1 Morning：The integration and challenges of regulatory science and the patent system

ü Latest Practices and Future Prospects of Drug Data Protection and Market Exclusivity Systems

ü How to Optimize Application Strategies and Quality Management of Biopharmaceutical Patents under the Fast-Track Patent Examination System

ü Patent Challenges in the ADC/Bispecific Antibody 2.0 Era

ü A New Balance Under Global Competition and Cooperation: Challenges, Evolution, and Multinational Corporate Strategies of Biopharmaceutical Patent Linkage Systems

Day 1 Afternoon：Maximizing Patent Value and New Commercialization Models

ü Biosimilar Patent Challenge Strategies and Patent Cliff Management

ü Patent Due Diligence and Investment Risks

ü Trade Secrets vs. Patent Trademarks: Biopharmaceutical Innovation Protection Strategies in High-Risk Litigation

ü Maximizing Innovation Value Using a Composite Intellectual Property Strategy (Patent + Data Protection)

ü Intellectual Property Risks and Management in the Context of Supply Chain Restructuring and Digital Therapy Compliance

Day 2 Morning：Global Perspective on Biopharmaceutical R&D and Patent Strategies and Competition

ü How to Develop Differentiated Claim Strategies to Cope with Strict Inventiveness/Obviousness Examinations in Various Countries

ü Patent Issues and Intellectual Property Risk Prevention in Cross-Border Biopharmaceutical Collaboration

ü Patent Layout and Cross-Border Expansion Strategies for Pharmaceutical Companies

ü Patent Issues in Cross-Border Biopharmaceutical Collaboration and Strategies for Protecting Pharmaceutical Intellectual Property

Day 2 Afternoon：Opportunities and Legal Challenges of AI in Biotechnology and Pharmaceutical Intellectual Property

ü Patent Challenges and Strategies for AI-Driven Drug Discovery, Gene Editing, and Cell and Gene Therapy

ü Patent Eligibility and Data Protection in AI-Driven Drug Development

ü Balance and Development of Innovative and Generic Drugs under the Drug Patent Linkage System

ü Deep Integration of AI in Drug Development and Intellectual Property Protection Strategies

Summit Presents:

300+ Participants

100+ Biotech & Pharma Companies

20+ Authoritative Speakers

10 Hours+ Networking

10+ Exhibition Booth

Partial inviting Companies & Institutions :

CNIPA	EUIPO	WIPO
PhIRDA	Eli Lilly and Company	Novo Nordisk
Johnson & Johnson	AbbVie	Merck Sharp & Dohme
Roche	AstraZeneca	Novartis
Pfizer	Amgen	Sanofi
GileadSciences	Bristol-Myers Squibb	Vertex Pharmaceuticals
Regeneron Pharmaceuticals	Novo Nordisk	Chugai Pharmaceutical
GSK	Merck KGaA	Sun Pharmaceutical
CVS Health	Daiichi Sankyō	LONZA
Takeda Pharmaceutical	Hengrui Pharmaceuticals	UCB
Argenx	Alnylam Pharmaceuticals Inc	Celltrion
Otsuka Holdings	Galderma Group	TEVA
WuXi AppTec	West Pharmaceutical	BeiGene
Biogen Inc	LabCorp	Bayer
Divis Laboratories	Sandoz	ICON
Astellas Pharma	Moderna	Baxter
Neurocrine Biosciences	Cipla Ltd.,	Viatris
Hansoh Pharm	Dr. Reddy's	Lupin Limited
Servier	Incyte, Corp	Genmab
Eisai	Luoxin Pharmaceutical Group	CSPC Pharma
Tide Pharmaceutical	BRILLIANT PHARMACEUTICAL	Innovent Biologics
Bio-Thera Solutions	Salubris Pharmaceuticals	Haiscom pharmaceutical
Easton Biopharmaceuticals	Hua Medicine	Genscript Corporation
TransThera Biosciences	CHIPSCREEN BIOSCIENCES	Humanwell Pharmaceutical
Fosun Kite Biotechnology	Hybio Pharmaceutical	Allist Pharmaceuticals
Xiangxue Life Sciences	Humanwell Healthcare	XuanZhu Pharma
Staidson	Shineway Pharmaceutical	Kanghong Pharmaceutical
I-Mab Biopharma	CRDC	New Era Pharmaceutical
Ascentage Pharma	ARSUAMOON	Jiangxi Jemincare Group
Yangzijiang Pharmaceutical	LintonPharm Co., Ltd.	Grand Pharmaceutical
Qilu Pharmaceutical	Shanghai Pharmaceuticals	Kelun Pharmaceutical
Buchang Pharmaceuticals	Livzon Pharmaceutical	SunshineLake
Huahai Pharmaceutical	Conba Pharmaceutical	3SBio Inc.
Jiuzhou Pharmaceutical	Hisun Pharmaceutical	Simcere Pharmaceutical
Beijing Intellectual Property Court	Shanghai Technology Exchange	Nhwa Pharmaceutical
Tongyuankang Pharmaceutical	Kangma Biotechnology	Rege Biotech
Zhejiang BaiChengPharmaceutical	Tongji University	HitGen Inc.
Impact Therapeutics	Hutchison China MediTech	CR Double Crane
Sinocelltech	Gendicine Biopharmaceutical	Shenyang Xingqi Pharmaceutical
Impact Therapeutics	Asieris Pharmaceuticals	Metsera
LaNova Medicines	Innolake Biopharm	Chengdu Guowei Biological
Ribo Life Science	Johnson & Johnson MedTech	Adlai Nortye
Kejun Pharmaceutical	Beijing Wuhe Boao Pharmaceutical	Youjia (Hangzhou) Biotechnology
Lyvgen Biopharma	Mabwell (Shanghai) Bioscience	IASO Bio
TOT Biopharm	Suzhou Gelanke Pharmaceutical	BioNTech
SanegeneBio	Medical Academy of Sciences & Research	Kangbaida (Sichuan) Biological
Shanghai Luoqi Biotechnology	Yuekang Kechuang Pharmaceutical	SunshineLake
Kelun-Bota Biotech	China Biologic Products	Junhemeng Biotech
Xiamen Amoytop Biotech	Yuansong Biotechnology	WuXi Biologics
J Xinnian Pharmaceutical	Shanghai Yunsheng Yanxin Biotech	Simcere Pharmaceutical

上海瞻仕商务咨询有限公司

上海瞻仕商务咨询有限公司是一家专注于金融，保险，生物，医药，互联网，能源化工等领域的峰会策划咨询机构。核心团队由十年以上会议行业人士组成，致力于为行业精英提供学习和交流平台，为客户提供行业鲜活的话题，解读热点的政策法规，分享前沿的创新技术。始终坚持“客户为本，合作发展，多元共赢”的经营理念，锐意进取，全力打造会议行业标杆。